Ad is loading...
CABA
Price
$1.87
Change
-$0.00 (-0.00%)
Updated
Nov 22 closing price
109 days until earnings call
RCKT
Price
$14.11
Change
+$1.32 (+10.32%)
Updated
Nov 22 closing price
102 days until earnings call
Ad is loading...

CABA vs RCKT

Header iconCABA vs RCKT Comparison
Open Charts CABA vs RCKTBanner chart's image
Cabaletta Bio
Price$1.87
Change-$0.00 (-0.00%)
Volume$4.64M
CapitalizationN/A
Rocket Pharmaceuticals
Price$14.11
Change+$1.32 (+10.32%)
Volume$1.19M
CapitalizationN/A
CABA vs RCKT Comparison Chart
Loading...
CABA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CABA vs. RCKT commentary
Nov 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Sell and RCKT is a Sell.

COMPARISON
Comparison
Nov 25, 2024
Stock price -- (CABA: $1.87 vs. RCKT: $14.11)
Brand notoriety: CABA and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 355% vs. RCKT: 124%
Market capitalization -- CABA: $91.4M vs. RCKT: $1.29B
CABA [@Biotechnology] is valued at $91.4M. RCKT’s [@Biotechnology] market capitalization is $1.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $468.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 1 FA rating(s) are green whileRCKT’s FA Score has 0 green FA rating(s).

  • CABA’s FA Score: 1 green, 4 red.
  • RCKT’s FA Score: 0 green, 5 red.
According to our system of comparison, both CABA and RCKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 4 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • CABA’s TA Score: 4 bullish, 5 bearish.
  • RCKT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CABA and RCKT are a bad buy in the short-term.

Price Growth

CABA (@Biotechnology) experienced а -38.28% price change this week, while RCKT (@Biotechnology) price change was +0.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

CABA is expected to report earnings on Mar 13, 2025.

RCKT is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($1.29B) has a higher market cap than CABA($91.4M). RCKT YTD gains are higher at: -52.920 vs. CABA (-91.762). CABA has higher annual earnings (EBITDA): -112.92M vs. RCKT (-247.25M). RCKT has more cash in the bank: 236M vs. CABA (183M). CABA has less debt than RCKT: CABA (15.2M) vs RCKT (25.6M). CABA (0) and RCKT (0) have equivalent revenues.
CABARCKTCABA / RCKT
Capitalization91.4M1.29B7%
EBITDA-112.92M-247.25M46%
Gain YTD-91.762-52.920173%
P/E RatioN/AN/A-
Revenue00-
Total Cash183M236M78%
Total Debt15.2M25.6M59%
FUNDAMENTALS RATINGS
RCKT: Fundamental Ratings
RCKT
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CABARCKT
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 19 days ago
87%
Bullish Trend 19 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Ad is loading...
CABA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FRBRX148.001.99
+1.36%
Franklin Biotechnology Discovery R6
SSEFX15.600.16
+1.04%
SouthernSun U.S. Equity, N
AUENX26.290.18
+0.69%
AQR Large Cap Defensive Style N
AGRDX62.730.17
+0.27%
American Century Growth R6
BULIX19.01-0.13
-0.68%
American Century Utilities Inv

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with RCKT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
N/A
RCKT - CABA
39%
Loosely correlated
+10.32%
PLRX - CABA
39%
Loosely correlated
+1.01%
SLRN - CABA
37%
Loosely correlated
+8.55%
PRME - CABA
37%
Loosely correlated
+7.74%
ALLO - CABA
37%
Loosely correlated
+4.74%
More

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with AXON. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
+10.32%
AXON - RCKT
52%
Loosely correlated
+0.90%
DNLI - RCKT
51%
Loosely correlated
+1.94%
ALEC - RCKT
51%
Loosely correlated
+4.79%
NTLA - RCKT
51%
Loosely correlated
+3.62%
PLRX - RCKT
50%
Loosely correlated
+1.01%
More